📰 Product Potency News

Product Potency News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Product Potency. Real-time updates on events, politics, business and more.

Mesoblast Reports Operational and Financial Highlights for

May 26, 2023

NEW YORK, May 25, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory...

United Kingdom United States Steve Dabkowski Paul Hughes Research Development Marrow Transplant Research

Source: globenewswire.com

Mesoblast Reports Operational and Financial Highlights for Quarter Ended March 31, 2023

May 26, 2023

26.05.2023 - NEW YORK, May 25, 2023 (GLOBE NEWSWIRE) - Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today reported operational highlights and financial results for the period ended March ...

United States United Kingdom Paul Hughes Steve Dabkowski Pharmaceuticals Co Drug Administration

Source: wallstreet-online.de

Remestemcel-L Clinical and Potency Studies Presented at Premier Meeting of Transplantation Research and Therapy

February 17, 2023

17.02.2023 - NEW YORK, Feb. 16, 2023 (GLOBE NEWSWIRE) - Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that two studies on the remestemcel-L development program for the ... Seite 1

United States Joanne Kurtzberg Duke University Medical Center Mesoblast Limited Nasdaq Marrow Transplant Research Drug Administration

Source: wallstreet-online.de

Remestemcel-L Clinical and Potency Studies Presented at

February 16, 2023

NEW YORK, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory...

United States Joanne Kurtzberg Steve Dabkowski Paul Hughes Marrow Transplant Research Drug Administration